307 results
8-K
EX-10.1
WINT
Windtree Therapeutics Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
AND SALE OF NOTES.
(a) Purchase of Notes . Subject to the satisfaction (or waiver) of the conditions set forth in Sections 6 and 7 below, the Company … purposes, but not, directly or indirectly, for (i) except as set forth on Schedule 4(d), the satisfaction of any indebtedness of the Company or any of its
8-K
WINT
Windtree Therapeutics Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
unless earlier converted or redeemed (upon the satisfaction of certain conditions) (the “Maturity Date”).
The Company may, subject to certain
8-K
EX-4.1
WINT
Windtree Therapeutics Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
10(a); and (ii) to the extent the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction … Stock issuable pursuant the event requiring the satisfaction of the Equity Conditions are duly authorized and listed and eligible for trading without
8-K
EX-3.1
7wv9mc6p
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-1.1
peed99 4mt9lda5ay
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
j02u1 e8x60h76bbca
9 Nov 23
Prospectus supplement for primary offering
4:11pm
8-K
EX-4.1
q2d4hy73q3q2vngyp
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
8-K
EX-1.1
ow9d5g 53
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
424B4
qhfi j0y0x
20 Apr 23
Prospectus supplement with pricing info
6:03pm